Japanese drugmaker Otsuka subsidiary Taiho Pharmaceutical has announced a collaboration agreement with USA-based Guardant ...

Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...

Placebo-subtracted mean weight loss up to 14.1%after 28 weeks with no plateauPotential for best-in-class tolerability with minimal diarrhea ...

Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...

The School of Criminology and Justice Studies is proud to announce a Dissertation Proposal by Xichen Wang entitled: "On the Measurement of Human Trafficking." Date: Friday, Oct. 10 Time: 10 a.m. - ...

A new pooled analysis of the FIBRONEER™-IPF and FIBRONEER™-ILD trials resulted in a nominally significant reduction in the risk of death by 59% ...

Gaumont USA has also just wrapped production on Diego Luna-led ‘Mexico 86,’ as it taps its huge library for international ...

Half of all financial assets worldwide are now held and intermediated by companies that are not classified and regulated as banks.

By Month 1, numerically fewer cumulative events were observed with acoramidis compared to placebo- Acoramidis significantly reduced the cumulative risk of CVM or recurrent CVH through Month 30 versus ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...

Research Progress of 3D Printing Combined with Virtual Reality Technology in Medical Education Practice: A Bibliometric ...

In today’s stock market, several news events are expected to impact stock prices. If you are looking to make profits through intraday trading, keeping an eye on these 20 stocks can be beneficial. CNBC ...